Endometriosis related pelvic pain affects approximately 8% of reproductive age women. Recently, the FDA approved a new oral GnRH antagonist for treatment of endometriosis related pelvic pain. This podcast will review the indication, data, and dosage options for this new novel medication. This podcast does not represent a specific endorsement of elagolix, and was produced without industry affiliation.
